FDA Approved: TEPMETKO — Original Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approves Tepmetko (tepotinib hydrochloride) under an original NDA for adults with metastatic non-small cell lung cancer harboring MET exon 14 skipping a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tepmetko (tepotinib)

Snippet

ORIG AP for TEPMETKO (TEPOTINIB HYDROCHLORIDE)